CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Pegaspargase (Oncaspar) Adult Acute Lymphocytic Leukemia (ALL) – Details

Brand Name Oncaspar
Generic Name Pegaspargase
Tumour Type Leukemia
Indication Adult Acute Lymphocytic Leukemia (ALL)
Review Status Not Filed
Manufacturer Servier Canada Inc.
Submission Type Non-Submission
Clarification CADTH is unable to recommend reimbursement of the relevant product because a submission to CADTH was not filed by the manufacturer.
Last Updated June 17, 2019